Navigation Links
Rigel Announces Fourth Quarter and Year End 2007 Financial Results
Date:2/12/2008

$3,128 $12,600 $33,473

Operating expenses:

Research and development

(see Note A) 21,960 15,002 70,364 56,968

General and administrative

(see Note A) 6,297 5,020 21,763 19,552

Total operating expenses 28,257 20,022 92,127 76,520

Loss from operations (20,257) (16,894) (79,527) (43,047)

Interest income, net 1,255 1,438 5,255 5,410

Net loss $(19,002) $(15,456) $(74,272) $(37,637)

Net loss per common share, basic

and diluted $(0.61) $(0.62) $(2.57) $(1.51)

Weighted average shares used in

computing net loss per common

share, basic and diluted 31,084 25,093 28,936 24,936

Note A

Stock-based compensation expense

included in:

Research and development $1,307 $1,317 $5,519 $6,515

General and adminstrative 1,259 1,125 6,168 6,064

$2,566 $2,442 $11,687 $12,579

SUMMARY BALANCE SHEET DATA

(in thousands)

December 31, December 31,

2007 2006(1)

(unaudited)

Cash, cash equivalents and

available for sale securities $108,296 $104,471

Total assets 115,789 113,240

Stockholder's equity 82,182 87,229

(1) Derived from audited financial statements


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Rigel to Present at BIO Investor Forum 2007
2. Rigel to Present Research Programs at Scientific Conferences
3. Rigel Announces Pricing of Public Offering of Common Stock
4. Rigel to Present at BIO CEO & Investor Conference
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... -- AmnioChor Inc., an early stage biotech startup based on ... that the Musculoskeletal Transplant Foundation of Edison ... seed round of development of the proprietary AmnioCept™ product ... AmnioChor,s technology allows cryopreservation of the amniotic membrane ... within those tissues. Amnion is a well-established source of ...
(Date:7/29/2015)... , July 29, 2015  Pfenex Inc. (NYSE MKT: ... results will be released on Thursday, August 13, 2015, ... Time, Pfenex management will host a conference call to ... A press release outlining the financial results and business ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) ...
(Date:7/29/2015)... ... 29, 2015 , ... The third Medical Innovation Impact Index (MI3) Alert considers ... drug/device combinations. The current system received a score of 0 (range -10 to +10) ... (iPCI) of Fairleigh Dickinson University’s ( FDU ) Rothman Institute of Innovation and ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
Breaking Biology Technology:The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... 9:00 a.m. Eastern Time on March 16, 2009 ... (Nasdaq: UTHR ) announced today that, based ... and Drug Administration (FDA), the FDA,s pending regulatory review ... treprostinil) will likely extend beyond its originally anticipated April ...
... Pangu BioPharma to SpeakSAN DIEGO, March 16 aTyr ... and development of an entirely new class of natural ... that it will participate at the ChinaBio(R) Investor Forum ... Cai, Senior Vice President of Clinical Development a aTyr ...
... cutting net operating expenses by approximately 50% in 2009 CTI ... March 16 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: ... fourth quarter and year ended December 31, 2008. Recent Events ... Met primary endpoint in the Phase ...
Cached Biology Technology:United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostinil (Tyvaso) 2United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostinil (Tyvaso) 3aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong 2Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 2Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 3Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 4Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 5Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 6Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 7Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 8
(Date:7/8/2015)... SPRINGS, Florida , July 8, 2015 ... constantly evolving as this summer,s must have products such as ... in demand as popularity for biometrics based devices continues to ... are NXT-ID, Inc. (NASDAQ: NXTD ), Google Inc. (NASDAQ: ... Inc. (NYSE: FIT ), GoPro, Inc. (NASDAQ: GPRO ...
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
(Date:7/2/2015)... GOTHENBURG, Sweden , July 2, 2015 ... fingerprint sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor ... is one of FPC,s distributors in Asia ... Q4 2015. The sensors will be used by smartphone manufacturers ... 268 MSEK is included in the communicated revenue guidance of ...
Breaking Biology News(10 mins):Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... , This release is available in French ... health. However, some people have inherited conditions that leave them ... prone to serious health problems, including developmental delay, psychosis, stroke ... genetic disease related to vitamin B12 deficiency by identifying a ...
... native vegetation offer birds "mini-refuges" and help to offset ... a study published today in the journal PLOS ... those with traditional grass lawns and non-native plantings. ... (NSF) Central Arizona-Phoenix Long-Term Ecological Research (LTER) site, one ...
... many reasons why it is important to be able to ... identification marks are essential for ensuring the correctness of breeding ... the possibility of deceit in competitions or when animals are ... relies on branding with hot irons or on ear-tagging but ...
Cached Biology News:Vitamin B12 deficiency: Tracking the genetic causes 2Native plants in urban yards offer birds 'mini-refuges' 2Native plants in urban yards offer birds 'mini-refuges' 3The end of an era? Branding horses does not enable them to be identified 2
...
... Mouse Monoclonal to L1 Cell Adhesion ... which is located in Xq28, is involved ... of the aqueduct of Sylvius); 2) MASA ... and 3) SPG1 (spastic paraplegia). ...
...
... One-Step FP Standardization Kit is used ... fluorescence polarization values of fluorescein solutions ... 2000 System. It also allows users ... by their instrument to the expected ...
Biology Products: